How we use molecular minimal residual disease (MRD) testing in acute myeloid leukaemia (AML).
Research output: Contribution to journal › Article › peer-review
Authors
Colleges, School and Institutes
Details
Original language | English |
---|---|
Journal | British Journal of Haematology |
Publication status | E-pub ahead of print - Oct 2020 |